Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.

This study has been completed.
Sponsor:
Collaborators:
Sanofi
Nektar Therapeutics
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00370565
First received: August 29, 2006
Last updated: February 9, 2007
Last verified: February 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2000
  Estimated Primary Completion Date: No date given